Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

Abstract Background Standard measures of response such as Response Evaluation Criteria in Solid Tumors are ineffective for bone lesions, often making breast cancer patients that have bone-dominant metastases ineligible for clinical trials with potentially helpful therapies. In this study we prospect...

Full description

Bibliographic Details
Main Authors: Mark Muzi, Lanell M. Peterson, Jennifer M. Specht, Daniel S. Hippe, Alena Novakova-Jiresova, Jean H. Lee, Brenda F. Kurland, David A. Mankoff, Nancy Obuchowski, Hannah M. Linden, Paul E. Kinahan
Format: Article
Language:English
Published: SpringerOpen 2024-03-01
Series:EJNMMI Research
Subjects:
Breast cancer
Bone metastases
18F-FDG PET
Test-retest
Repeatability
Online Access:https://doi.org/10.1186/s13550-024-01093-7

Internet

https://doi.org/10.1186/s13550-024-01093-7

Similar Items